Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 5/20 | 0.65 |
| ▸ | F2 | P00734 | 2/20 | 0.63 |
| ▸ | F10 | P00742 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 4/20 | 0.52 |
| ▸ | MMP9 | P14780 | 3/20 | 0.52 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.52 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.52 |
| ▸ | EDNRA | P25101 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4134328 | 1.00 | TYMS (0.65) | TYMSF2F10ALDH1A1MAPT | |
| SCHEMBL9052993 | 1.00 | TYMS (0.65) | TYMSF2F10ALDH1A1MAPT | |
| SCHEMBL29829755 | 1.00 | TYMS (0.65) | TYMSF2F10ALDH1A1MAPT | |
| SCHEMBL29597077 | 0.92 | F2 (0.63) | TYMSF2F10EDNRAPTGS2 | |
| SCHEMBL27578159 | 0.92 | F2 (0.63) | TYMSF2F10EDNRAPTGS2 | |
| SCHEMBL29941510 | 0.88 | TYMS (0.81) | TYMSF2F10PTGS2 | |
| SCHEMBL4325460 | 0.88 | TYMS (0.81) | TYMSF2F10PTGS2 | |
| SCHEMBL5706271 | 0.87 | TYMS (0.54) | TYMSF2EDNRA | |
| SCHEMBL6266410 | 0.87 | TYMS (0.54) | TYMSF2EDNRA | |
| SCHEMBL17351925 | 0.86 | TYMS (0.57) | TYMSF2F10EDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189317-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | ACADIA WOODS PARTNERS, LLC | 2024-06-13 | — | — | US | claimed |
| EP-2934555-B1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2021-09-22 | — | — | EP | claimed |
| CN-105749890-A | Chiral stationary phase prepared by taking cinchonidine-boc-amide as chiral selector as well as preparation method and application thereof | 河南科技学院 | 2016-07-13 | — | — | CN | claimed |
| CN-105642261-A | Chiral stationary phase prepared with cinchonine-Boc-amide as chiral selector and preparation method and application thereof | 河南科技学院 | 2016-06-08 | — | — | CN | claimed |
| CN-105561959-A | Chiral stationary phase prepared by taking quinine-tertiary butyl carbamate as a chiral selector and preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-05-11 | — | — | CN | claimed |
| CN-105498736-A | Chiral stationary phase prepared by taking quinindium-t-butyl carbamate as chirality selector as well as preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-04-20 | — | — | CN | claimed |
| US-5541633-A | Ink jet printing of concealed images on carbonless paper | XEROX CORPORATION (US) | 1996-07-30 | — | — | US | claimed |
| US-5286286-A | Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores | XEROX CORPORATION (US) | 1994-02-15 | — | — | US | claimed |
| JP-7146282-A | — | — | None | — | — | JP | disclosed |
| CN-119174932-A | Preparation method of capillary chromatographic column based on metal organic framework material and used for chiral separation | 上海大学 | 2024-12-24 | — | — | CN | disclosed |
| CN-114504843-B | Preparation method of capillary open-tube chromatographic column based on metal organic framework material | 上海大学 | 2023-05-02 | — | — | CN | disclosed |
| CN-114504843-A | Preparation method of capillary open-tube chromatographic column based on metal organic framework material | 上海大学 | 2022-05-17 | — | — | CN | disclosed |
| EP-3313566-B1 | PREPARATION OF MOLECULARLY IMPRINTED POLYMERS BY TWO-PHOTON STEREOLITHOGRAPHY | CENTRE NAT RECH SCIENT (FR) | 2019-06-05 | — | — | EP | disclosed |
| EP-3313566-A1 | PREPARATION OF MOLECULARLY IMPRINTED POLYMERS BY TWO-PHOTON STEREOLITHOGRAPHY | Centre National De La Recherche Scientifique (FR) | 2018-05-02 | — | — | EP | disclosed |
| EP-1200932-A1 | PORTABLE AUTHENTICATION DEVICE AND METHOD OF AUTHENTICATING PRODUCTS OR PRODUCT PACKAGING | Verification Technologies, Inc. d/b/a Veritec (US) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001006453-A1 | PORTABLE AUTHENTICATION DEVICE AND METHOD OF AUTHENTICATING PRODUCTS OR PRODUCT PACKAGING | VERIFICATION TECHNOLOGIES, INC. D/B/A VERITEC (US) | 2001-01-25 | — | — | WO | disclosed |
| US-5629424-A | Stereoselective adsorptive bubble process | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1997-05-13 | — | — | US | disclosed |
| US-5541633-A | Ink jet printing of concealed images on carbonless paper | XEROX CORPORATION (US) | 1996-07-30 | — | — | US | disclosed |
| JP-H07146282-A | SEPARATION AGENT FOR CHROMATOGRAPHY | Y M SHII:KK | 1995-06-06 | — | — | JP | disclosed |
| US-5286286-A | Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores | XEROX CORPORATION (US) | 1994-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240189317-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | PIKFYVE, APAF1, API5 | TYMS 690/4885F2 600/4885F10 1288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.